Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

publishing date : 2021 - 04 - 27    symbols : SRNE    save search

Sorrento Receives FDA Clearance to Proceed With Phase 2 Study for Sti-3031, an Anti-Pd-L1 Antibody, for Advanced Urothelial Carcinoma
Published: 2021-04-27 (Crawled : 16:00) - globenewswire.com
SRNE | $0.015 56K twitter stocktwits trandingview |
Health Technology
| | O: -1.43% H: 9.54% C: 6.4%

fda clearance fda phase 2 antibody clearance urothelial carcinoma
Gainers vs Losers
64% 36%

Top 10 Gainers
CSSE 4 | $0.3686 142.02% 76M twitter stocktwits trandingview |
Consumer Services

CZOO | $11.685 134.17% 7.6M twitter stocktwits trandingview |

BOF | $1.93 64.96% 55M twitter stocktwits trandingview |

AMST | $3.14 57.0% 59M twitter stocktwits trandingview |
Technology Services

TROO | $1.57 44.04% 2.8M twitter stocktwits trandingview |
Manufacturing

RILY | $30.87 42.13% 7.8M twitter stocktwits trandingview |
Finance

LICN | $0.76 35.71% 6.2M twitter stocktwits trandingview |

WHLM | $6.61 30.12% 400K twitter stocktwits trandingview |
Commercial Services

MULN | News | $3.53 29.3% 4.8M twitter stocktwits trandingview |
Information

RBBN 4 | $3.26 26.85% 1.2M twitter stocktwits trandingview |
Electronic Technology


Your saved searches
Save your searches and get alerts when important news are released.